Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Agios Pharmaceuticals, Inc.

Latest From Agios Pharmaceuticals, Inc.

EU Fast-Track Requests For Mozafancogene Autotemcel & Vorasidenib Signal Imminent Filings

The European Medicines Agency is this week deciding whether its reviews of planned marketing applications from Rocket Pharmaceuticals and Servier merit accelerated assessment status.

Europe Review Pathway

Q3 Earnings: Surveying The Small Biopharma Launch Scene

Several small biopharmas are launching new drugs independently, sales of some of those drugs appear to be off to a slow start.

Launches Sales & Earnings

Servier Continues Oncology Winning Streak With Tibsovo Approval For MDS

The targeted therapy won approval for myelodysplastic syndrome patients with IDH1 mutations, who have a higher propensity for progression to acute myeloid leukemia.

Approvals Business Strategies

Deal Watch: Novartis, Ionis Team Up Again In Cardiovascular Disease

Plus deals involving ProQR/ Thea, Aeglea/Immedica, Ayala/Biolight, Quince/EryDel, ImmunoBiochem/ImmunoGen and GSK/LimmaTech, as well as deals in brief.

Deal Watch Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals